An updated meta-analysis of oxidative stress markers in bipolar disorder

Despite its debilitating symptoms, the pathophysiology of bipolar disorder (BD) remains unclear. One consistently compelling finding, however, has been the presence of oxidative stress. In the present investigation, we conducted a meta-analysis of studies that measured oxidative stress markers in BD patients compared to healthy controls. Search terms and selection criteria were determined a priori to identify and include all studies that measured a marker of oxidative stress in BD compared to healthy controls. Eight markers were included: superoxide dismutase, catalase, protein carbonyl, glutathione peroxidase, 3-nitrotyrosine, lipid peroxidation, nitric oxide, and DNA/RNA damage. A meta-analysis of standardized means was conducted using a random-effects model with generic inverse weighting. Between-study heterogeneity, publication bias, and sensitivity analyses were also examined for each marker. Twenty-seven papers were included in the meta-analysis, which comprised a total of 971 unique patients with BD and 886 healthy controls. Lipid peroxidation, DNA/RNA damage, and nitric oxide were significantly increased in BD patients compared to healthy controls. Additionally, the effect size for lipid peroxidation was very high. Publication bias was not detected for any of the markers. The main limitations in this meta-analysis are the high degree of heterogeneity between studies and the small number of studies used in the analysis of some markers. Additionally, the sensitivity analysis indicated that some results are not very robust. The results from this meta-analysis support the role of oxidative stress in bipolar disorder, especially to DNA, RNA, and lipids.

[1]  Maurício Kunz,et al.  Increased oxidative stress and DNA damage in bipolar disorder: A twin-case report , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[2]  R. Pinheiro,et al.  Peripheral oxidative damage in early-stage mood disorders: a nested population-based case-control study. , 2012, The international journal of neuropsychopharmacology.

[3]  D. Kupfer,et al.  Bipolar disorder diagnosis: challenges and future directions , 2013, The Lancet.

[4]  Omer Akyol,et al.  Antioxidant enzyme activities and oxidative stress in affective disorders , 2004, International clinical psychopharmacology.

[5]  Ana Cristina Andreazza,et al.  DNA damage in bipolar disorder , 2007, Psychiatry Research.

[6]  H. Herken,et al.  Possible Role of Nitric Oxide and Adrenomedullin in Bipolar Affective Disorder , 2002, Neuropsychobiology.

[7]  Michael Berk,et al.  Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[8]  J. Fullerton,et al.  Assessing oxidative pathway genes as risk factors for bipolar disorder. , 2010, Bipolar disorders.

[9]  T. S. Sathyanarayana Rao,et al.  Evidence of altered DNA integrity in the brain regions of suicidal victims of Bipolar Depression , 2010, Indian journal of psychiatry.

[10]  C. Konradi,et al.  Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia , 2011, International Journal of Developmental Neuroscience.

[11]  A. Kerkeni,et al.  Reduced antioxidant defense systems in schizophrenia and bipolar I disorder , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[12]  C. Lin,et al.  The Identification and Characterization of Oxidized RNAs in Alzheimer's Disease , 2003, The Journal of Neuroscience.

[13]  Jun-Feng Wang,et al.  Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder , 2013, Journal of neurochemistry.

[14]  G. MacQueen,et al.  G Protein‐Coupled Cyclic AMP Signaling in Postmortem Brain of Subjects with Mood Disorders , 1999, Journal of neurochemistry.

[15]  S. Selek,et al.  Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[16]  C. Beasley,et al.  Decreased mRNA expression of uncoupling protein 2, a mitochondrial proton transporter, in post-mortem prefrontal cortex from patients with bipolar disorder and schizophrenia , 2011, Neuroscience Letters.

[17]  Etelvino J. H. Bechara,et al.  Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic-depressive patients. , 1986, Clinical chemistry.

[18]  Jun-Feng Wang,et al.  Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness. , 2010, Journal of psychiatry & neuroscience : JPN.

[19]  Y. Surh,et al.  Differential cell death induced by salsolinol with and without copper: possible role of reactive oxygen species. , 2001, Molecular pharmacology.

[20]  S. Selek,et al.  Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: Impact of past episodes , 2006, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[21]  Jun-Feng Wang,et al.  Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. , 2011, The international journal of neuropsychopharmacology.

[22]  N. Kato,et al.  Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins , 2008, Molecular Psychiatry.

[23]  M. Rehli,et al.  5-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytes , 2013, Genome Biology.

[24]  C. Zarate,et al.  Effects of lithium on oxidative stress parameters in healthy subjects. , 2011, Molecular medicine reports.

[25]  H. Stunnenberg,et al.  5-Hydroxymethylcytosine: a new kid on the epigenetic block? , 2011, Molecular systems biology.

[26]  N. Tarrier,et al.  Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment , 1999, BMJ.

[27]  R. Machado-Vieira,et al.  Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: A possible role for lithium antioxidant effects , 2007, Neuroscience Letters.

[28]  Benicio N Frey,et al.  Oxidative stress markers in bipolar disorder: a meta-analysis. , 2008, Journal of affective disorders.

[29]  F. Benes,et al.  DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia , 2007, Schizophrenia Research.

[30]  C. Gottfried,et al.  Serum S100B and antioxidant enzymes in bipolar patients. , 2007, Journal of psychiatric research.

[31]  Jun-Feng Wang,et al.  Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. , 2009, Bipolar disorders.

[32]  S. Selek,et al.  The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode. , 2008, Journal of affective disorders.

[33]  M. Leboyer,et al.  Biomarkers in bipolar disorder: A positional paper from the International Society for Bipolar Disorders Biomarkers Task Force , 2013, The Australian and New Zealand journal of psychiatry.

[34]  P. Ranjekar,et al.  Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients , 2003, Psychiatry Research.

[35]  Xiangmei Wu,et al.  Oxidative stress induces DNA demethylation and histone acetylation in SH-SY5Y cells: potential epigenetic mechanisms in gene transcription in Aβ production , 2013, Neurobiology of Aging.

[36]  K. Chang,et al.  Early intervention for symptomatic youth at risk for bipolar disorder: a randomized trial of family-focused therapy. , 2013, Journal of the American Academy of Child and Adolescent Psychiatry.

[37]  H. Herken,et al.  The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder , 2004, European Archives of Psychiatry and Clinical Neuroscience.

[38]  Flávio Kapczinski,et al.  Peripheral biomarkers and illness activity in bipolar disorder. , 2011, Journal of psychiatric research.

[39]  F. Kapczinski,et al.  3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. , 2009, Journal of psychiatry & neuroscience : JPN.

[40]  O. Değer,et al.  Treatment with lithium, alone or in combination with olanzapine, relieves oxidative stress but increases atherogenic lipids in bipolar disorder. , 2007, The Tohoku journal of experimental medicine.

[41]  A. Carvalho,et al.  Number of manic episodes is associated with elevated DNA oxidation in bipolar I disorder. , 2013, The international journal of neuropsychopharmacology.

[42]  A. Dasgupta,et al.  Effects of lithium therapy on Na+–K+-ATPase activity and lipid peroxidation in bipolar disorder , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[43]  D. Kupfer,et al.  Elevated serum measures of lipid peroxidation and abnormal prefrontal white matter in euthymic bipolar adults: toward peripheral biomarkers of bipolar disorder , 2012, Molecular Psychiatry.

[44]  N. Craddock,et al.  The beginning of the end for the Kraepelinian dichotomy , 2005, British Journal of Psychiatry.

[45]  H. Canatan,et al.  Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder , 2002, Cell biochemistry and function.

[46]  Jun-Feng Wang,et al.  Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. , 2010, Archives of general psychiatry.

[47]  S. Lightfoot,et al.  Effects of N-Acetylcysteine Plus Mesalamine on Prostaglandin Synthesis and Nitric Oxide Generation in TNBS-Induced Colitis in Rats , 2009, Digestive Diseases and Sciences.

[48]  DNA fragmentation decreased in schizophrenia but not bipolar disorder. , 2003, Archives of general psychiatry.